Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Actinogen Medical Limited (ATGGF)
OTHER OTC:ATGGF
RESEARCH TOOLSreports
Actinogen Medical Limited (ATGGF) Stock Price & Analysis
16 Followers
ATGGF Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range<$0.01 - $1.00
Previous Close$0.5
Volume73.00K
Average Volume (3M)N/A
Market Cap
$145.90M
Enterprise Value$135.07M
Total Cash (Recent Filing)AU$16.37M
Total Debt (Recent Filing)AU$165.27K
Price to Earnings (P/E)―
Beta-21.20
Next Earnings
Aug 28, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding2,326,920,711
10 Day Avg. Volume0
30 Day Avg. VolumeN/A
Standard Deviation1.20
R-Squared0.03
Alpha0.38
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Actinogen Medical Limited News
PremiumCompany Announcements
Actinogen Medical’s Promising Clinical Trials Progress
PremiumCompany Announcements
Actinogen Medical Seeks Quotation for New Shares
PremiumCompany Announcements
Actinogen Medical Seeks New Securities QuotationPremiumCompany Announcements
Actinogen Medical Applies for Additional ASX QuotationPremiumCompany Announcements
Actinogen Medical Expands Shares Quotation
PremiumCompany Announcements
Actinogen Medical Advances Novel Brain TherapiesPremiumCompany Announcements
Actinogen Medical Applies for New ASX Quotation
PremiumCompany Announcements
Actinogen Medical Applies for New ASX QuotationOptions Prices
Currently, No data available
---
Ownership Overview
5.65% Insiders
0.00% Mutual Funds
<0.01% Other Institutional Investors
94.35% Public Companies and
Individual Investors
ATGGF FAQ
What was Actinogen Medical Limited’s price range in the past 12 months?
Actinogen Medical Limited lowest stock price was <$0.01 and its highest was $1.00 in the past 12 months.
What is Actinogen Medical Limited’s market cap?
Currently, no data Available
When is Actinogen Medical Limited’s upcoming earnings report date?
Actinogen Medical Limited’s upcoming earnings report date is Aug 28, 2024 which is in 36 days.
How were Actinogen Medical Limited’s earnings last quarter?
Actinogen Medical Limited released its earnings results on Feb 25, 2024. The company reported -$0.004 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.004.
Is Actinogen Medical Limited overvalued?
According to Wall Street analysts Actinogen Medical Limited’s price is currently Overvalued.
Does Actinogen Medical Limited pay dividends?
Actinogen Medical Limited does not currently pay dividends.
What is Actinogen Medical Limited’s EPS estimate?
Actinogen Medical Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Actinogen Medical Limited have?
Actinogen Medical Limited has 2,699,027,600 shares outstanding.
What happened to Actinogen Medical Limited’s price movement after its last earnings report?
Actinogen Medical Limited reported an EPS of -$0.004 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Actinogen Medical Limited?
Currently, no hedge funds are holding shares in ATGGF
---
Actinogen Medical Limited Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
ATGGF Sentiment 100%
Sector Average 72%
Sector Average 72%
Insider Transactions
Bought Shares
Worth $125.2K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
0.00%
12-Months-Change
Fundamentals
Return on Equity
-102.54%
Trailing 12-Months
Asset Growth
-20.02%
Trailing 12-Months
Company Description
Actinogen Medical Limited
Actinogen Medical Ltd is a biotechnology company. The company develops drugs for Alzheimer's disease and the cognitive decline associated with other neurological and metabolic diseases. Geographically, it operates and derives revenue from Australia.
---
Technical Analysis
---